Karin Hardiman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Karin Hardiman

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancer Cytopathology|July 20, 2012

Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasiaTerry K Morgan, Karin Hardiman, Christopher L Corless, et al.

Oncotarget|October 15, 2017

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequencyJoseph Dosch, Elizabeth Ziemke, Shanshan Wan, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017

Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancerXiang Xue, Bryce X Bredell, Erik R Anderson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancer Cytopathology|July 20, 2012

Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasiaTerry K Morgan, Karin Hardiman, Christopher L Corless, et al.

Oncotarget|October 15, 2017

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequencyJoseph Dosch, Elizabeth Ziemke, Shanshan Wan, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017

Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancerXiang Xue, Bryce X Bredell, Erik R Anderson, et al.

Pageof 2